% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

  • showman01 showman01 Aug 26, 2013 8:28 AM Flag

    NPSP next?

    Any thoughts on AMGN looking at NPSP? Makes a lot of sense as they already pay NPSP a substantial royalty through 2018 on Sensipar, have a strong presence in the cancer treatment area and the newest NPSP drug is GATTEX for small bowl syndrome, something that can be caused by cancer of the bowel. With another potential blockbuster orphan drug in the offing (NATPARA) it makes a lot of sense.


    Sentiment: Buy

144.72+3.26(+2.30%)Feb 12 4:00 PMEST